Table of Contents
Overview
Zatolmilast is a phosphodiesterase inhibitor. It has mostly been investigated for its ability to treat asthma and chronic obstructive pulmonary disease (COPD). Phosphodiesterase inhibitors operate by inhibiting the enzyme phosphodiesterase, resulting in higher amounts of cyclic AMP (cAMP) and cyclic GMP (cGMP), which are molecules that regulate a variety of cellular processes. The Food and Drug Administration approved Zatolmilast on 27th September 2023
Drug Group
Zatolmilast belongs to the drugs category known as phosphodiesterase 4 (PDE4) inhibitors.
For Patients:
What Is Fragile X Syndrome?
Fragile X syndrome is a genetic condition that causes developmental delays, intellectual incapacity, and behavioral problems. It is caused by a mutation in the FMR1 gene, which produces inadequate fragile X mental retardation protein (FMRP). Symptoms include intellectual incapacity, social issues, hyperactivity, and unusual physical characteristics. While there is no cure, treatments like therapy and medication can help alleviate symptoms.
How Does Zatolmilast Work?
Zatolmilast inhibits phosphodiesterase 4 (PDE4), which prevents the breakdown of cyclic adenosine monophosphate (cAMP). Elevated cAMP levels have anti-inflammatory effects, regulate the immunological response, and modulate neurotransmission. This mechanism suggests that Zatolmilast might be used to treat inflammatory problems like asthma as well as neurological disorders like Fragile X syndrome.
What Are the Things to Inform the Doctor Before Taking Zatolmilast?
-
Medical History: Provide a complete medical history, including any pre-existing problems such as heart disease, liver disease, renal disease, gastrointestinal disorders, mental health issues, or other chronic illnesses.
-
Allergies: Inform the doctor if one has any known allergies or hypersensitivity to medicines, food, or other substances, especially if one has previously reacted to PDE inhibitors or similar therapies.
-
Current Medications: Please list all medications being taken, including prescriptions, over-the-counter pharmaceuticals, vitamins, supplements, and herbal items. Certain drugs may interact with Zatolmilast, reducing its efficacy or raising the risk of unwanted effects.
-
Pregnancy and Nursing: If the person is pregnant, intend to become pregnant, or is nursing, inform the doctor about the risks and advantages of using Zatolmilast. Zatolmilast's safety during pregnancy and lactation has not been proven. Therefore, the healthcare practitioner will assess the possible benefits against the dangers.
-
Special Precautions: Discuss any Zatolmilast-related precautions or warnings, such as the possibility of mental side effects (for example, mood changes, suicidal thoughts), cardiovascular effects (for example, heart palpitations), or gastrointestinal problems (for example, nausea, diarrhea).
How Is Zatolmilast Administered?
Zatolmilast is normally given orally in the form of pills or capsules. A healthcare expert should establish the appropriate dosage and administration instructions based on the ailment being treated, the patient's age, weight, and other considerations. It is critical to adhere to the dosage and administration schedule recommended by the doctor or pharmacist. Zatolmilast can be taken with or without meals, as indicated. Unless otherwise ordered by a healthcare professional, swallow the whole tablet or capsule without crushing, chewing, or breaking it.
Dietary Instructions:
-
Avoid Alcohol: It is generally suggested that one should restrict or avoid alcohol consumption while taking Zatolmilast since it might raise the risk of some side effects, including dizziness and sleepiness.
-
Stay Hydrated: Drinking enough water is essential when taking Zatolmilast, especially if one has gastrointestinal side effects such as nausea or diarrhea. Staying hydrated can help to relieve these symptoms.
-
Caffeine Intake: While there are no specified caffeine limits with Zatolmilast usage, excessive caffeine consumption may increase some adverse effects such as jitteriness or sleeplessness. Be cautious of one’s caffeine intake and consider lowering it if necessary.
-
Discuss Supplements: Before starting Zatolmilast, talk to the doctor about any dietary supplements or herbal products one may be taking. Some supplements may interact with drugs, affecting their absorption and efficacy.
-
Consistency With Meals: Whether to take Zatolmilast with or without meals is usually determined by personal preferences and tolerance. Maintaining consistency with meals (for example, taking it with food or on an empty stomach) may assist in maximizing absorption and reducing gastrointestinal side effects.
-
Follow Prescribed Dosage: Follow the dosage guidelines advised by the doctor or pharmacist. Taking Zatolmilast as prescribed is critical for attaining the intended therapeutic outcomes while limiting the possibility of adverse effects.
Side Effects:
-
Gastrointestinal Issues: Nausea, vomiting, diarrhea, or abdominal discomfort are all possible gastrointestinal issues.
-
Headache: Some people may report headaches after using Zatolmilast.
-
Insomnia or Sleep Disturbances: Zatolmilast may disrupt sleep patterns in some people, causing difficulties sleeping or staying asleep. It may also produce dizziness or lightheadedness, particularly when getting up suddenly from a sitting or sleeping posture.
-
Mood Changes: Zatolmilast might induce mood swings, such as irritation or anxiety.
-
Elevated Liver Enzymes: Zatolmilast can occasionally induce a rise in liver enzyme values, which may suggest liver inflammation or injury.
-
Allergic Responses: Allergic responses to Zatolmilast are infrequent but possible. Symptoms include rash, itching, swelling of the face, lips, or tongue, and trouble breathing.
Missed Dose:
If a dosage of Zatolmilast is missed, take it as soon as recalled unless it is almost time for the next dose to be administered. In that case, skip the missing dosage and resume the usual dosing schedule. Do not double the dose to make up for the missing one. Consistency with the dose schedule is critical for the medication's effectiveness. If one has any concerns or questions regarding missing doses, the healthcare practitioner or pharmacist can help. Depending on the unique scenario, they can provide personalized recommendations to assist with efficient missed dose management.
Overdose:
If an overdose on Zatolmilast is observed, get medical help or call a poison control center immediately. Overdose symptoms may include severe dizziness, nausea, vomiting, diarrhea, headaches, and an elevated heart rate. It is critical not to exceed the recommended dosage of Zatolmilast and to adhere to the directions provided by the healthcare professional or pharmacist.
Storage:
Zatolmilast should be kept at room temperature and free from moisture and heat. It should be kept in its original container, out of the reach of children and dogs. Zatolmilast should not be stored in the bathroom or kitchen since moisture levels may be higher there. Additionally, keep the drug in a secure area to avoid accidental intake or misuse. If the prescription comes with special storage instructions, follow them carefully. Ask the pharmacist for advice if one has any queries regarding how to store Zatolmilast.
For Doctors:
Indication:
Zatolmilast is used to treat inflammatory disorders such as asthma, COPD, and IBD. It may also be studied for its possible application in neurological illnesses such as Fragile X syndrome, where it might help alleviate cognitive impairments. However, precise indications may change based on regulatory approvals and continuing research findings. Always adhere to the healthcare provider's advice for properly using Zatolmilast for one’s condition.
Contraindication:
Zatolmilast should not be used if one has a known hypersensitivity to it or any of its components. Furthermore, it may not be appropriate for people with severe hepatic impairment. However, precise contraindications may differ based on an individual's health state and the existence of other medical disorders. Always consult a healthcare expert for individualized information on Zatolmilast contraindications.
What Are the Pharmacological Aspects of Zatolmilast?
-
Mechanism of Action: Zatolmilast selectively inhibits phosphodiesterase 4 (PDE4). This inhibits PDE4, hindering the breakdown of cyclic adenosine monophosphate (cAMP), resulting in higher intracellular cAMP levels. This increase in cAMP levels regulates various cellular activities, including immunological responses, inflammation, and neurotransmission.
-
Pharmacokinetics: Zatolmilast is normally taken orally and is quickly absorbed in the gastrointestinal tract. Its maximal plasma concentration occurs within a few hours of dosing. Zatolmilast is extensively metabolized in the liver by the cytochrome P450 enzyme system, particularly through the CYP3A4 route. The metabolites are mostly expelled in the feces, with a minor amount removed through the urine.
-
Pharmacodynamics: Zatolmilast's principal pharmacodynamic impact is the inhibition of PDE4, which results in higher cAMP levels within cells. This increase in cAMP levels has a variety of downstream consequences, including anti-inflammatory properties, immunological regulation, and possible impacts on synaptic plasticity in the central nervous system.
Drug Interaction:
-
CYP3A4 Inhibitors: Zatolmilast is metabolized predominantly via the cytochrome P450 enzyme system, namely the CYP3A4 pathway. The concurrent use of potent CYP3A4 inhibitors, such as some antifungal medicines (for example, Ketoconazole, Itraconazole) or HIV protease inhibitors, may raise Zatolmilast plasma concentrations, increasing the risk of adverse consequences.
-
CYP3A4 Inducers: Strong CYP3A4 inducers, such as Rifampin or Carbamazepine, may lower Zatolmilast plasma levels, lowering its effectiveness.
-
Other PDE4 Inhibitors: Using other phosphodiesterase 4 (PDE4) inhibitors with Zatolmilast may raise the possibility of additive pharmacological effects, such as excessive cAMP buildup and an increased risk of adverse effects.
-
QT Prolonging Drugs: Zatolmilast may cause an electrocardiogram (ECG) to show a longer QT interval. Concurrent usage with other medicines that lengthen the QT interval, such as some antiarrhythmics, antipsychotics, or antibiotics, may raise the risk of significant cardiac arrhythmias.
-
Alcohol: Drinking alcohol while taking Zatolmilast may enhance the central nervous system depressant effects of both drugs, resulting in more significant sedation, dizziness, or reduced motor function.
Clinical Studies:
-
Asthma and COPD: Zatolmilast has been studied in several clinical studies to treat asthma and chronic obstructive pulmonary disease. These trials examined how it affected airway inflammation, lung function, and symptom management compared to placebo or conventional therapies. Some patients showed promising anti-inflammatory benefits and improved lung function indicators.
-
Inflammatory Bowel Disease (IBD): Preliminary studies have examined the possibility of Zatolmilast for the treatment of inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. These trials examined its ability to reduce intestinal inflammation and improve symptoms such as stomach discomfort, diarrhea, and rectal bleeding.
-
Fragile X Syndrome: Zatolmilast has also been studied for its possible use in Fragile X syndrome, a neurodevelopmental condition characterized by intellectual incapacity and behavioral problems. Clinical investigations have examined its impact on cognitive function, behavior, and synaptic plasticity in people with fragile X syndrome. Early data point to potential improvements in cognitive and behavioral problems, while more study is needed.
-
Safety and Tolerability: Clinical trials have also examined the safety and tolerability of Zatolmilast, including its side effect profile, possible medication interactions, and long-term efficacy. These studies have yielded valuable information on adverse events, dosage regimens, and patient treatment techniques.
Specific Considerations:
-
Liver Function Monitoring: Zatolmilast may affect liver function; thus, frequent monitoring of liver enzymes is recommended, especially in individuals with pre-existing liver illness or those taking other drugs known to influence liver function.
-
Cardiac Monitoring: Zatolmilast may extend the QT interval on an electrocardiogram (ECG), increasing the risk of severe cardiac arrhythmias. As a result, caution should be exercised when providing Zatolmilast to patients with pre-existing cardiac problems or those on other drugs that are known to lengthen the QT interval.
-
Psychiatric Symptoms: Some people may develop mood changes, such as irritation or anxiety while using Zatolmilast. Patients should be closely watched for mental problems, particularly during the early phases of therapy or when dosages are altered.
-
Drug Interactions: Zatolmilast may interact with other drugs, such as CYP3A4 inhibitors and inducers, altering its metabolism and effectiveness. Before providing Zatolmilast, healthcare practitioners should evaluate the patient's prescription list for any potential interactions.
-
Pregnancy and Breastfeeding: Zatolmilast's safety during pregnancy and breastfeeding has yet to be proven. Pregnant or nursing women should discuss the possible risks and benefits of Zatolmilast with their doctor before beginning therapy.
-
Pediatric Use: Zatolmilast's safety and effectiveness in pediatric patients have not been demonstrated. Its use in children and adolescents should be carefully assessed, considering individual circumstances and clinical judgment.
-
Geriatric Use: Elderly people are more likely to have Zatolmilast side effects, such as dizziness and gastrointestinal difficulties. When prescribing Zatolmilast to geriatric individuals, close monitoring is required.
-
Smoking Status: Since smoking has been shown to increase CYP3A4 activity, it may influence Zatolmilast metabolism. When calculating the right Zatolmilast dosage, healthcare practitioners should take into account the patient's smoking status.
